CompuGroup Medical SE & Co. KGaA (CGM), one of the leading e-health companies in the world, acquired VISUS Health IT GmbH (VISUS), one of the leading providers for Picture Archiving and Communication Systems (PACS) and Healthcare Content Management in Germany.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Viamed, one of Spain's leading private hospital groups, announced that Philips has been selected to install the latest advanced diagnostic imaging solutions in clinical centers throughout Viamed's network, supporting the group's healthcare professionals to further improve patient care.
Academic analysis shows primary care prescribers have been preventing adverse drug reactions, harm and hospital admissions through safer prescribing, after using prescribing tech. The company behind the system also reveals that GPs have helped save hundreds of millions of pounds.
To maximize the data pool, it is customary to share patient data between clinics by sending copies of databases to the clinics where the algorithm is being trained.
Black Country Pathology Services has worked with CliniSys to create the ICE Portal, a web-based application that makes it easy for care homes, or other community care settings, to be able to order lab based COVID-19 tests and see the results.
The European Commission is inviting public health stakeholders to submit initiatives for anew cycle of Thematic Networks under the EU Health Policy Platform. The purpose of a Thematic Network is to produce a Joint Statement within a year, summarising the common position of a group of stakeholder organisations on one of the following selected public health areas:
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its newest solution for precision diagnosis with the global introduction of its spectral detector-based Spectral Computed Tomography (CT) 7500. This latest intelligent system delivers high quality spectral images for every patient on every scan 100% of the time to help improve disease characterization, and reduce rescans and follow-ups, all at the same dose levels as conventional scans.